National cosmetic surgery provider The Hospital Group has undertaken a restructure of its shareholder base and secured its future entirely through internal funding.
Having considered seeking investment through venture capital, The Hospital Group – which is based at Dolan Park near Bromsgrove – chose to ensure the certainty of the company’s finances by remaining independent.
David Ross, Chief Executive of The Hospital Group, said: “By excluding external investors, The Hospital Group is now in a strong position to control its own agenda for future development and we are really excited about the potential that this opens up for us.”
Mr Ross added: “The restructure gives us a solid base from which we can deliver our strategic company vision to be the market leader in the UK and Ireland for the provision of elective lifestyle surgery and treatments, recognised for quality, value and innovation.”
This latest move follows the acquisition of Marbella-based Mills & Mills earlier this year and the appointment of leading surgeon Mr Mario Russo, while plans to expand further into the USA are also on the cards.
Following the restructure, the Company is projecting a very healthy 12.5% increase in turnover. Expectations are high, but for a company that has added 3 UK and 4 Irish and 12 Spanish clinics to the network in the last 16 months, clearly business is booming.
